Skip to Content

'
Lois M. Ramondetta, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Chief, Division of Gynecologic Oncology, Lyndon B. Johnson General Hospital, Harris Health System, Houston, TX

Bio Statement

 

 

Dr. Lois M. Ramondetta joined the M.D. Anderson Gynecologic Oncology Department after completing her fellowship in 2000. She holds a full time Professor faculty position at M.D. Anderson Cancer Center and she is currently the Chief of Gynecologic Oncology at Lyndon Baines Johnson General Hospital, Harris County Hospital District. She is a key member of the M.D. Anderson Outreach Program, which provides quality cancer care at regional medical centers, and trains fellows, residents, and medical students in the field of gynecologic oncology. Aside from direct patient care and resident training, she has chaired or co-chaired the HCHD Cancer Committee since 2004 which is responsible for all cancer related activities in the District and assuring accreditation of-the district by the American College of Surgeons.

 

Caring for patients at both MD Anderson and the indigent patients in the county, she is extremely active in developing and running clinical trials in both locations. She is the Principal Investigator or co-PI for several treatment and psycho-social trials at M.D. Anderson and Lyndon Baines Johnson Hospital, and has been integral in bringing these trials to the community through the outreach program. She focuses her clinical research on biomedical ethics, and the effect of spirituality during cancer treatment, and quality of life and on treatment trials for cervical and endometrial cancer and participates actively in treatment trials for ovarian cancer. One of her passions is to evaluate and eliminate barriers to care for the indigent patients afflicted with gynecologic cancer. She has published over 70 peer reviewed articles and authored many book chapters on cancer treatment and palliative care.

 

She has served on the Memorial Hermann and University of Texas M.D. Anderson Clinical Bioethics Committee. She has completed three year terms on the American College of Obstetrician and Gynecologist’s (ACOG) Ethics Committee and the American Society of Clinical Oncologist’s (ASCO) Ethics Committee. In 2010, she became Board Certified in Palliative Care.

 

She has a BA in Religion and a BS in Biology from Emory University, has completed a Lay Chaplaincy program, and has a strong interest in improving physician-patient communication. In 2008, she co-wrote a book with a patient and friend entitled, "The Light Within" published by William Morrow a division of HarperCollins that further explores the sanctity of the doctor patient relationship.

 

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 1362
Houston, TX 77030-4009
Room Number: CPB6.3249
Phone: (713) 745-0307
Fax: (713) 792-7586
Email: lramonde@mdanderson.org

Education & Training

Degree-Granting Education

1993 Robert Wood Johnson Medical Center, Piscataway, NJ, MD, Medical School
1989 Emory University, Atlanta, GA, BA, Religion
1989 Emory University, Atlanta, GA, BS, Biology
1988 Emory University, Atlanta, GA, BA, Lay Chaplaincy Program

Postgraduate Training

7/1997-6/2000 Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, David M. Gershenson, MD
7/1993-6/1997 Resident, OB/GYN, Thomas Jefferson University Hospital, Philadelphia, PA, Cynthia Silber, MD

Board Certifications

11/2010 American Board of Obstetrics and Gynecology - Diplomate, Hospice and Palliative Medicine
2005 American College of Surgeons - Fellow
4/2003 American Board of Obstetrics and Gynecology - Diplomate, Obstetrics and Gynecology and Gynecologic Oncology
12/2001 American Board of Obstetrics and Gynecology - Diplomate, Obstetrics and Gynecology
1994 National Board of Medical Examiners of the United States - Diplomate

Experience/Service

Other Appointments/Responsibilities

Member, Cancer Committee, Texas Medical Association, Austin, TX, 10/2008-present
Chairman, District Cancer Committee, Harris County Hospital District, Houston, TX, 2006-2009
Member, Medical Staff, Obstetrics and Gynecology Service, Women's Hospital of Texas, Houston, TX, 2003-2013
Member, Medical Staff, Obstetrics and Gynecology Service, Memorial Hermann Hospital, Houston, TX, 1/2002-present
Member, Medical Staff, Obstetrics and Gynecology Service, St. Luke's Episcopal Hospital, Houston, TX, 1/2002-3/2012
Member, Harris County Cancer Committee, Harris County Hospital District, Houston, TX, 2001-present

Institutional Committee Activities

Member, PROSPR Advisory Committee, 2/2011-present
Advisory Board, GAP Sister Institution KHCC, 2010-present
Chair, MDACC Comprehensive Cancer Center Initiative - Cervix Work Group, 2010-present
Member, Psychosocial Council, 2009-2011
Chair, Administrative Research Working Group - Cervix, 2009-2010
Chair, Endometrial Working Group, 2006-2009
Member, The University of Texas M.D. Cancer Center Uncompensated Care Advisory Committee, 2005-present
Member, HCHD/MDACC Medical/Administrative Advisory Committee Meeting, 2005-2010
Member, Cervix Working Group, 2003-2008
Member, Clinical Ethics Committee, 2003-2006
Member, Task Force, Spirituality in the Workplace, Office of Institutional Diversity, 2003-2005
Member, HCHD External Joint Operations Committee, 2002-present
Member, Endometrial Working Group, 2002-2009

Honors and Awards

2013-2014 The Kathryn S. Stream Award for Excellence in Women's Health, Texas Medical Center Women's Health Network
2012 APGO Excellence in Teaching Award, M.D. Anderson Cancer Center
2011-present Top Doctors in Cervical Cancer, U.S. News and World Report
2010 Shawnee High School Alumni Hall of Fame Inductee, Shawnee High School Alumni
2009 Excellence in Patient Care Award Nominee, Katherine Stream Foundation
2009 Julie and Ben Rogers Award for Excellence in Patient Care, Julie and Ben Rogers Foundation
2008 National Minority Cancer Awareness Week Community Award, MD Anderson Cancer Center
2008 Who's Who of Executive and Professional Women, Brittmore
2005 Educator of the Month, UT M. D. Anderson Cancer Center
2003 Nursing Professional Development & Education Award, UT M. D. Anderson Cancer Center, Houston, TX
2003 Organon Award for Outstanding Research Paper, UT Medical School, Houston, TX
2003 Outstanding Educator, The Education Week Committee, UT M. D. Anderson Cancer Center, Houston, TX
2002 Faculty Recognition Award for Dedication to Patient Care and Resident Teaching, LBJ Hospital, Houston, TX
2002 Who's Who in Medicine and Health Care, Marquis Who's Who in Medicine and Health Care
2000 National Gynecologic Oncology Fellow's Forum, SmithKline Beecham
1996 Best Abstract Award, American Association of Colposcopy and Cervical Pathology
1993 Alumni Award, Robert Wood Johnson Medical School, Piscataway, NJ
1992 Alpha Omega Alpha Honor Society, Robert Wood Johnson Medical School, Piscataway, NJ
1989-1991 President, Student Body, Robert Wood Johnson Medical School, Piscataway, NJ
1986-1989 Dean's List, Emory University, Atlanta, GA

Selected Publications

Peer-Reviewed Original Research Articles

1. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjunct chemotherapy for FIGO stage I-IIIA uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 5/2013. e-Pub 2/4/2013. PMID: 23385150.
2. Ramondetta L. What is the appropriate approach to treating women with incurable cervical cancer? J Natl Compr Canc Netw 11, Number 3(March 2013):348-355, 3/1/2013. PMID: 23486459.
3. Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecol Oncol 127(3):451-5, 12/2012. e-Pub 9/14/2012. PMID: 22986144.
4. Juloori A, Klopp A, Ramondetta L, Jhingran A, Euscher E, Fleming N, Lu K, Eifel P. Radiation therapy in the management of carcinosarcoma of the uterus. Int J Radiat Oncol Biol Phys 84 (3S)(2630):S456, 10/2012.
5. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer 22(7):1203-7, 9/2012. PMID: 22810967.
6. Ramondetta L, Zaid TM, Wallace AM. "Doctor, what did I do to deserve this? Palliat Support Care 9(4):425-427, 12/2011. PMID: 22104419.
7. Seth SG, Goka T, Harbison A, Hollier L, Peterson S, Ramondetta L, Noblin SJ. Exploring the role of religiosity and spirituality in amniocentesis decision-making among Latinas. J Genet Couns 20(6):660-73, 12/2011. e-Pub 6/2011. PMID: 21695589.
8. Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C. Work related stress among gynecologic oncologists. Gynecol Oncol 123(2):365-369, 11/2011. e-Pub 7/2011. PMID: 21777966.
9. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 117(9):1928-1934, 5/2011. e-Pub 11/2010. PMID: 21082702.
10. Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A Phase II trial of Paclitaxel and Carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer 21(3):517-522, 4/2011. PMID: 21436700.
11. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol 204(4):355.e1-7, 4/2011. e-Pub 2/2011. PMID: 21324431.
12. Ramondetta L, Brown A, Richardson G, Urbauer D, Thaker PH, Koenig HG, Gano JB, Sun C. Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making. Int J Gynecol Cancer 21(3):573-581, 4/2011. PMCID: PMC3127444.
13. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer 117(5):1070-1079, 3/1/2011. e-Pub 10/19/2010. PMCID: PMC3065823.
14. Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC. Ethics consultation on a gynecologic oncology service: an opportunity for physician education. J Cancer Educ 26(1):183-7, 3/2011. e-Pub 9/2010. PMID: 20835927.
15. Kincey J, Westin SN, Zhao B, Curtis MG, Ramondetta L. Surgical removal of a gigantic abdominal mass: a multidisciplinary approach. Obstet Gynecol 117(2 Pt 2):508-512, 2/2011. PMID: 21252807.
16. Juius JM, Ramondetta L, Tipton KA, Lai LS, Schneider K, Smith JA. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy 31(3):280-297, 2011.
17. Slomovitz BM, Lu KH, Johnston T, Coleman RL, Munsell M, Broaddus RR, Walker C, Ramondetta LM, Burke TW, Gershenson DM, Wolf J. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer 116(23):5415-9, 12/2010. e-Pub 8/2010. PMID: 20681032.
18. Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A Gynecologic Oncology Group Study. Gynecol Oncol 119(3):531-7, 12/2010. e-Pub 9/15/2010. PMID: 20837359.
19. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 12/2010. e-Pub 9/15/2010. PMID: 20837355.
20. Ramondetta LM, Ramirez P. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-425, 12/2010. e-Pub 9/2010. PMID: 20837355.
21. Brown J, Smith JA, Ramondetta LM, Sood AK, Ramirez PT, Coleman RL, Levenback CF, Munsell MF, Jung M, Wolf JK. Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer 116(21):4973-9, 11/1/2010. PMID: 20665499.
22. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists. Gynecol Oncol 119(2):291-4, 11/2010. e-Pub 8/12/2010. PMID: 20708226.
23. Clements A, Euscher E, Lacour R, Merritt W, Klopp A, Ramondetta L. The presence of human papilloma virus or p16 in six cases of retroperitoneal carcinoma. Obstet Gynecol 116(5):1042-1046, 11/2010. PMID: 20966687.
24. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol 4(1):13-21, 2010. e-Pub 11/2010. PMCID: PMC3016100.
25. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 27(28):4649-55, 10/1/2009. e-Pub 8/31/2009. PMCID: PMC2754911.
26. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 10/2009. e-Pub 7/25/2009. PMID: 19632709.
27. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer 19(6):1107-12, 8/2009. PMID: 19820377.
28. Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer 1(115):1867, 5/1/2009. e-Pub 2/2009. PMID: 19241422.
29. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-8, 3/2009. e-Pub 12/25/2008. PMCID: PMC2666540.
30. Coker AL, Eggleston KS, Du XL, Ramondetta LM. Ethnic disparities in cervical cancer survival among medicare eligible women in a multiethnic population. Int J Gynecol Cancer 19(1):13-20, Jan-Feb, 1/2009. PMID: 19258935.
31. Gaikwad A, Wolf J, Brown J, Ramondetta LM, Smith J. In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines. J Oncol Pharm Pract 15(1):35-44, 8/2008. e-Pub 8/2008. PMID: 18753181.
32. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM (Mentoring Author). In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol 62(3):483-489, 8/2008.
33. Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. Journal of Oncology Pharmacy Practice 14:31-36, 3/2008.
34. Westin SN, Bustillos D, Gano JB, Fields MM, Coker AL, Sun CC, Ramondetta LM (Mentoring Author). Social factors affecting treatment of cervical cancer: ethical issues and policy implications. Obstet Gynecol 111(3):747-51, 3/2008. PMID: 18310380.
35. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1):118-25, 1/2008. e-Pub 9/2007. PMID: 17869451.
36. Smith J, Gaikwad A, Yu J, Wolf J, Brown J, Ramondetta L, Stewart C. In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines. Cancer Chemother Pharmacol, 9/2007.
37. Slieper CF, Wasson K, and Ramondetta LM. From Technician to Professional: Integrating Spirituality into Medical Practice. Am J Bioethics 7(7):26-7, 7/2007.
38. Lin YG, Deavers M, Sasan F, Zager JS, Ramondetta LM (Mentoring Author). Clinical challenges presented by three simultaneous solid tumors. Gynecol Oncol 103:1159-63, 12/2006. PMID: 17055558.
39. Pothuri B, Ramondetta LM, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol 103(3):948-51, 12/2006.
40. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol 103:547-53, 11/2006. PMID: 16730784.
41. Smith JA, Gaikwad A, Ramondetta LM, Wolf JK, Brown J. Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecol Oncol 103:518-22, 11/2006. PMID: 16690105.
42. Canada AL, Parker PA, de Moor JS, Basen-Engquist K, Ramondetta LM, Cohen L. Active coping mediates the association between religion/spirituality and quality of life in ovarian cancer. Gynecol Oncol 101:102-7, 4/2006. PMID: 16256181.
43. Canada AL, Parker PA, Basen-Engquist K, de Moor JS, Ramondetta LM. Active coping mediates the association between religion/spirituality and functional well-being in ovarian cancer. Gynecol Oncol 99:S125, 12/2005. PMID: 16450431.
44. Stevens TA, Brown J, Zander DS, Bevers MW, Gershenson DM, Ramondetta LM (Mentoring Author). Adult granulosa cell tumors of the ovary in two first-degree relatives. Gynecol Oncol 98:502-5, 9/2005. PMID: 15992917.
45. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM (Mentoring Author). Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol 98:77-83, 7/2005. PMID: 15907988.
46. Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas. Appl Immunohistochem Mol Morphol 13:167-70, 6/2005. PMID: 15894930.
47. Jenkins AD, Ramondetta LM (Mentoring Author), Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 97:840-4, 6/2005. PMID: 15882895.
48. Orejuela FJ, Ramondetta LM (Mentoring Author), Smith J, Brown J, Lemos LB, Li Y, Hollier LM. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol 97:483-8, 5/2005. PMID: 15863148.
49. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer 15:510-6, 5/2005. PMID: 15882178.
50. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97:489-96, 5/2005. PMID: 15863149.
51. Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol 95:32-6, 10/2004. PMID: 15385107.
52. Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol 94:442-8, 8/2004. PMID: 15297186.
53. Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer 14:580-8, 7/2004. PMID: 15304150.
54. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786-96, 3/1/2004. PMID: 14967435.
55. Ramondetta LM, Sills D. Spirituality in gynecological oncology: a review. Int J Gynecol Cancer 14(2):183-201, Mar-Apr, 3/2004. PMID: 15086714.
56. Smith JA, Brown J, Martin MC, Ramondetta LM, Wolf JK. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Gynecol Oncol 92(1):314-9, 1/2004. PMID: 14751176.
57. Ramondetta LM, Sills D. Spirituality and religion in the "art of dying". J Clin Oncol 21(23):4460-2, 12/1/2003. PMID: 14645439.
58. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91(3):463-9, 12/2003. PMID: 14675663.
59. Shvartsman HS, Langstein H, Worley C, Malpica A, Ramondetta LM. The role of vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva. Obstet Gynecol 102(5 Pt 2):1163-6, 11/2003. PMID: 14607043.
60. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets. Gynecol Oncol 90(3):529-36, 9/2003. PMID: 13678720.
61. Pothuri B, Ramondetta L, Martino M, Alektiar K, Eifel PJ, Deavers MT, Venkatraman E, Soslow RA, Barakat RR. Development of endometrial cancer after radiation treatment for cervical carcinoma. Obstet Gynecol 101(5 Pt 1):941-5, 5/2003. PMID: 12738155.
62. Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Mentorship and productivity among gynecologic oncology fellows. J Cancer Educ 18(1):15-9, 2003. PMID: 12825629.
63. Holtz D, Ramondetta LM, Burke TW, Palazzo JP, Dunton CJ, Atkinson EN, Broaddus RR. PTEN expression in tamoxifen-associated endometrial cancers. Anticancer Res 22(5):2945-8, Sep-Oct, 9/2002. PMID: 12530022.
64. Ramondetta LM, Silva EG, Levenback CF, Burke TW. Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer 12(3):312-6, May-Jun, 5/2002. PMID: 12060455.
65. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Gynecol Oncol 83(3):543-8, 12/2001. PMID: 11733969.
66. Ramirez PT, Ramondetta LM, Burke TW, Gershenson DM, Brewer MA. Metastatic uterine papillary serous carcinoma to the pericardium. Gynecol Oncol 83(1):135-7, 10/2001. PMID: 11585425.
67. Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol 82(1):156-61, 7/2001. PMID: 11426978.
68. Gordinier ME, Ramondetta LM, Parker LP, Wolf JK, Follen M, Gershenson DM, Bodurka-Bevers D. Survey of female gynecologic oncologists and fellows: balancing professional and personal life. Gynecol Oncol 79(2):309-14, 11/2000. PMID: 11063663.
69. Ramondetta L, Mills GB, Burke TW, Wolf JK. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res 6(1):278-84, 1/2000. PMID: 10656459.
70. Ramondetta LM, Sherwood JB, Dunton CJ, Palazzo JP. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 180(2 Pt 1):340-1, 2/1999. PMID: 9988797.
71. Ramondetta LM, Palazzo JP, Dunton CJ, Kovatich AJ, Carlson JA. A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas. Anticancer Res 18(6B):4661-5, Nov-Dec, 11/1998. PMID: 9891537.
72. Ramondetta LM, Carlson JA, Schwarting R. Atypical Meigs' syndrome and bilateral ovarian stromal hyperplasia; A case report. J Reprod Med 42(9):603-5, 9/1997. PMID: 9336761.
73. van Hoeven KH, Ramondetta L, Kovatich AJ, Bibbo M, Dunton CJ. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol 16(1):15-21, 1/1997. PMID: 8986527.
74. Ramondetta LM, Dunton CJ, Shapiro MJ, Carlson JA, Arsuaga J. Percutaneous abscess drainage in gynecologic cancer patients. Gynecol Oncol 62(3):366-9, 9/1996. PMID: 8812534.

Invited Articles

1. Ramondetta LM. The Importance of Hope During Treatment. Coping Magazine(Jan/Feb 2012):20-21, 1/2012.
2. Diekem DS, Fallat ME, Antommaria AH, Holzman IR, Katz AL, Leuthner SR, Ross LF, Webb SA, Weise KL, Ralston SJ, Lyerly AD, Bernstein J, Brincat CA, Burda ML, Childress JF, Farrell RM, Frederickson HL, Kroncke FG, Marshall MF, Minkoff HL, Ramondetta LM, Spillman MA, Werden JJ. Maternal-fetal Intervention and Fetal Care Centers. Pediatrics 128(2):473-478, 8/2011. PMID: 21788223.
3. Ramondetta LM. End of Life Issues. Obstetrics and Gynecology: ACOG Ethics Committee-Opinion, 2008.
4. Ramondetta L. Lymphatic anatomy and physiology. Op Tech Gyn Surg 6:7-12, 2001.

Editorials

1. Ramondetta LM, Jhingran A. Eleven Years: The Long and Winding Road. Gynecol Oncol 107(2)(2):166-168, 11/2007. PMID: 17950382.
Other Articles
1. Aga I, Ramondetta LM, Kilpatrick CC, Orejuela FJ. Intra-operative Anaphylaxis-Undiagnosed Latex Allergy. The Female Patient. e-Pub 7/2009.
2. Hosemann S, Jhingran A, Ramondetta LM. Researchers seek to understand the mysteries of uterine cancer and to find better treatments. OncoLog. MD Anderson OncoLog 49((10)), 2004.
3. Ramondetta L Gott I. The cancer that sends out an early warning. The University of Health Science Center, Houston publication, Health Leader, 10/2002.
4. Ramondetta L Gott I. CA-125 and ovarian cancer. It may not be the "Ah-HAH", but it might be the Hmmm Part II. The University of Texas Health Science Center at Houston publication, Health Leader, 9/2002.
5. Ramondetta L Gott I. CA-125: Not the "Ah-HAH" for diagnosing ovarian cancer. Part I. The University of Texas Health Science Center at Houston publication, Health Leader, 9/2002.
6. Burke T, Jhingran A, Ramondetta L. Guidelines for endometrial cancer. Clinical Discussion: Endometrial cancer. MD Anderson OncoLog 47((12)), 2002.

Abstracts

1. Bradford A, Ramondetta LM, Soliman PT, Westin SN. Symptoms of posttraumatic stress disorder in women who have undergone exenterative pelvic surgery for treatment of gynecologic malignancy. SGO 2013 Annual Meeting on Women's Cancer, Los Angeles, CA(0549), 3/2013.
2. Ramondetta L, Kang Y, Hu W, Sun C, Kott M, Deavers M, Klopp A, Thaker P, Smith J, Sood A. The clinical significance of beta adrenergic receptor expression in cervical cancer tissue. SGO 2013 Annual Meeting on Women's Cancer, Los Angeles, CA(0604), 3/2013.
3. Silvas EV, Ramondetta LR. 2012 Cervical Cancer Summit: Raising awareness, identifying barriers. 2012 CPRIT Conference, Cervical Cancer Summit(69), 12/2012.
4. Bradford A, Urbauer D, Palencia J, Panto C, Nogueras-Gonzalez G, Bodurka D, Sun C, Ramondetta L. Assessment of sexual dysfunction in medically underserved patients with gynecologic cancers. 2012 World Meeting on Sexual Medicine, Chicago, IL(425), 8/2012.
5. Ramondetta LM, Urbauer D, Zhukovsky DS, Bevers MW, Brown J, Bodurka DC, Thaker PH, Sun CC. Longitudinal study of hope, meaning/peace (M/P) and quality of life (QOL) in patients (pts) with ovarian cancer (OC). 2012 ASCO Annual Meeting, Chicago, IL(100101), 6/2012.
6. Ramondetta L, Sun C, Konishi T, Baider L, Ripamonti C, Olver I, Johnson J, Surbone A. Surprising results regarding MASCC members and beliefs about spiritual care. MASCC/ISOO 2012 International Symposium on Supportive Care in Cancer, New York, NY 20(Suppl 1):S136-137, 6/2012.
7. Frumovitz M, Macapinlac H, Ramondetta L, Klopp A. Anatomic location of PET positive paraaortic nodes in patients with locally advanced cervcal cancer. 17th International Meeting of the European Society of Gynaecological Oncology, Milan, Italy(A-373-0004-01327), 9/2011.
8. Ramondetta LR, Sun, CC. Protective effects of spirituality and religiosity in underserved women with cervical cancer (CxCa). Suppportive Care in Cancer, MASCC/ISOO 2011 International Symposium, Athens, Greece 19(2 - June 2011):S316, #723 (#A-327-0027-00723), 6/2011.
9. Bodurka D, Sun C, Jhingran A, Urbauer D, Levenback C, Eifel P, Ramondetta L, Ramirez P, Frumovitz M. Schover L. A longitudinal evaluation of sexual functioning and quality of life in cervical cancer survirors. 42nd Annual Meeting of the Society of Gynecologic Oncologists, Orlando, Florida 120(187) (#187), 3/2011.
10. Euscher E, Wei C, Ramondetta L, Broaddus R. Reverse-phase protein lysate array identified popential therapeutic targets in uterine carcinosarcoma. 42nd Annual Meeting of the Society of Gynecologic Oncologists, Orlando, Florida 120(212) (#212), 3/2011.
11. Ramondetta LM, Zhukovsky D, Urbauer DL, Basen-Enquist K, Levenback C, Bevers M, Thacker P, Sun C. Factors Contributing to Anxiety, Depression in Newly Diagnosed Ovarian Cancer Patients. MASCC 2010 Supportive Care in Cancer. Vancouver, BC Canada, 6/2010.
12. Bodurka DC, Jhingran A, Ramondetta LM, Eifel PJ, Crane CH, Phan AT, Urbauer DL, Frumovitz MM, Elting LS, Sun CC. Visual analog scale (VAS) and time trade-off (TTO) preferences for side effects (SE) of chemoradiation (chemoXRT): A comparison of patients (pts) and caregivers (CG). ASCO 2010 Annual Meeting; Chicago, IL, June 4, 2010, 6/2010.
13. Ramondetta LM. Barriers to Cervical Cancer Screening in Medically Underserved Women: Still more to be done. Society of Gynecologic Oncologists 41st Annual Meeting on Women's Cancer, 3/2010.
14. Ramondetta LM, Sun C,. The Effects of Hope and Spirituality on Quality of Life (QOL) in Newly Diagnosed Ovarian Cancer Patients. IGCS Annual 2010 Meeting, Prague, Czech Republic, 2010.
15. Burzawa JJ, Schmeler KM, Soliman PT, Lacour RA, Meyer LA, Bevers MW, Frumovitz MM, Pustlnik TN. Brown J, Anderson ML, Ramondetta LM, Tortolero-Luna G, Gershenson DM, Lu K. Prospective, population-based evaluation of insulin resistance, polycystic ovary syndrome and metabolic syndrome in a cohort of patients with endometrial cancer. Gynecol Oncol 112, Suppl 1(2):S85 (#170), 2/2009.
16. Gano JB, Palencia JI, Folloder JK, Hughes MK and Ramondetta LM. Assessment of the prevalence of sexual dysfunction, depression and anxiety in underserved and minority patients with gynecologic cancers. Onc Nurs Forum, 10th Annual Conference on Cancer Nursing Research, 36(1):Abstract 67 (#67), 1/2009.
17. Johnson AJ, Urbauer DL, Achanta LM, Thaker PH, Kavanagh JJ, Koenig HG, Ramondetta LM. Gynecologic Oncologists Have a High Internal Locus of Control. IGCS 2008 12th Biennial Meeting, International Gynecologic Cancer Society, 10/2008.
18. Ramondetta LM, Johnson AJ, Urbauer DL, Achanta LM, Thaker PH, Kavanagh JJ, Koenig HG, Sun CC. Religion and Spiritual Beliefs in Gynecologic Oncologist. IGCS 2008 12th Biennial Meeting, International Gynecologic Cancer Society, 10/2008.
19. Ramondetta LM, Johnson AJ, Urbauer DL, Achanta LM, Thaker PH, Kavanagh JJ, Koenig HG, Sun CC. Religion and Spirituality: How Gynecologic Oncologist Ask. IGCS 2008 12th Biennial Meeting, International Gynecologic Cancer Society, 10/2008.
20. Ramondetta LM, Johnson AJ, Sun CC, Achanta L, Kavanagh J, Koenig H. A Survey on the Role of Religion and Spirituality in Gynecologic Oncologist. MASCC/ISOO 2008 International Symposium, 6/2008.
21. Gano J, Haun L, Palenica J, Urbauer D, Folloder J, Ramondetta LM,. Assessment of the Prevalence of Sexual Dysfunction, Depression and Anxiety in Underserved and Minority Patients with Gynecologic Cancers. MASCC/ISOO 2008 International Symposium, 6/2008.
22. Sun CC, Aguilliard J, Jhingran A, Eifel P, Crane CH, Phan A, Ramondetta LM, Frumovitz MF, Elting L, Bodurka DC. Preferences for Side Effects of Chemoradiation: Focus on Nausea and Vomiting. 2008 Annual Meeting of the Multinational Association for Supportive Care in Cancer, 6/2008.
23. Slomovitz BM, Lu KH, Johnston T, Munsell M, Ramondetta LM, Broaddus RR, Coleman RL, Walker C, Gershenson DM, Burke TW, Wolf J. A Phase II study of oral mammalian target of rapamycin (mTOR) inhibitor, RAD001 (everolimus), in patients with recurrent endometrial carcinoma (EC). ASCO Annual Meeting (#5502), 2008.
24. Monk BJ, Sill M, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J. A randomized phase III trial of four cisplatin (CIS) containing doublet combinations in stage IVB, recurrent or persistent cervical carcinoma: A Gynecologic Oncology (GOG) study. ASCO Annual Meeting 2008, 2008.
25. Wenzel LB, Huang H, Cella D, Monk BJ, Sill MW, Mckeekin SD, Cohn DE, Ramondetta LM, Boardman CH, Benda J. Quality of Life results of a randomized phase III trial of four cisplatin (CIS) containing doublet combinations instage IVB cervical carcinoma: A Gynecologic Oncology Group (GOG) study. ASCO Annual Meeting (#5529), 2008.
26. Thaker P, Sun CC, Bodurka D, Palmer JL, Pei BL, Willey J, Bruera E, Ramondetta LM,. Quality of Life, Spirituality, and Locus of Control in a Palliative Care Setting. MASCC/ISOO 2008 International Symposium, 2008.
27. Ramondetta LM, Lacour RA, Euscher ED, Iyer RB, Atkinson EN, Gano JB, Milam MR, Ramirez PT, Levenback CF, Burke, TW. A Phase II Multicenter Trial of Paclitaxel and Carboplatin in Women with Advanced or Recurrent Malignant Mixed Mullerian Tumors (MMMT) of the Uterus. ASCO Annual Meeting (#5589), 6/2007.
28. Burke TW, Navo MA, Smith JA, Jung MS, Broaddus R, Iyer RB, Lu KH, Sun CC, Atkinson EN, Ramondetta LM. Phase II trial of Mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma (LGESS). ASCO Annual Meeting (#5595), 6/2007.
29. Gaikwad A, Yu J, Ramirez P, Ramondetta L, Smith JA. Characterization of Hormone Receptor Expression in Gynecologic Cancer cell lines. Presentation at the AACR Annual Meeting, Los Angeles, CA (#3534), 4/2007.
30. Milam MR, Gano J, Ramondetta LM, Brown J, Jhingran A, Deavers M, Ramirez PT. Laparoscopic Extraperitoneal Lymph Node Dissection in Patients with Locally Advanced Cervical Cancer: A Pilot Study. Poster selected for 38th Annual Society of Gynecologic Oncologists Meeting (#264), 2007.
31. Thaker PH, Sun C, Bodurka DC, Palmer JL, Pei B, Willey J, Breuera E, Ramondetta LM. Spirituality, quality of life, and locus of control in a palliative care setting. Proceedings of the Annual Meeting of the American Society of Clinical Oncology (#18529), 6/2006.
32. Slomovitz B, Lu K, Burke TW, Soliman PT, Schmeler K, Munsell M, Johnston T, Coleman R, Ramondetta L, Gershenson DM, Wolf J. mTOR is a rational target for the treatment of endometrial cancer: Preliminary results of a phase II study of RAD001 for patients with recurrent endometrial cancer. Proceedings of the 37th Annual Meeting of the Society of Gynecologic Oncologists:S110 (#253), 3/2006.
33. Thaker PH, Sun C, Bodurka DC, Palmer JL, Pei BL, Willey J, Bruera E, Ramondetta LM. Spirituality and locus of control in a palliative care setting. Proceedings of the 37th Annual Meeting of the Society of Gynecologic Oncologists:S107 (#247), 3/2006.
34. Milam MR, Slomovitz BM, Schmeler KM, Soliman PT, Ramirez PT, Sun C, Eifel PJ, Ramondetta LM, Lu KH. Management and patterns of recurrence of women with occult stage II endometrioid endometrial cancer. Proceedings of the 37th Annual Meeting of the Society of Gynecologic Oncologists:S177 (#413), 2006.
35. Slomovitz BM, Ramondetta LM, Crotzer D, Soliman P, Schmeler K, Broaddus RR, Sun CC, Gershenson DM, Burke TW, Lu KH. Clinical and pathologic review of clear cell carcinoma of the endometrium: A single institution study of 81 patients. Gynecol Oncol 96:903-1020 (#92), 3/2005.
36. Slomovitz BM, Burke TW, Soliman PT, Ramondetta LM, Eifel PJ, Jhingran A, Wolf J, Sun CC, Gershenson DM, Lu KH. Patterns of recurrence of uterine papillary serous carcinoma. Gynecol Oncol 96:909-1020 (#83), 3/2005.
37. Lee, CM, Slomovitz BM, Greer M, Sharma S, Burke T, Gershenson DM, Lu KH, Ramondetta LM (Mentoring Author). Practice patterns of SGO members for stage IIIA endometrial cancers. Proceedings Society of Gynecologic Oncologists Annual Meeting on Women's Cancer, Fountainebleau Hilton Resort, Miami Beach, FL, 3/2005.
38. Slomovitz BM, Coleman R, Soliman PT, Ramondetta LM, Wolf J, Sun CC, Gershenson DM, Burke TW, Lu KH. Is there a survival difference between clear cell and serous carcinoma of the endometrium? A stage and age-matched cohort study of high-risk endometrial carcinoma: Is there a difference between clear cell and serous carcinoma?. Proceedings of the American Society of Clinical Oncology 41st Annual Meeting 23:5081, 2005.
39. Jarrett L, Brown J, Hollier L, Sun C, Hughes A, Jhingran A, Ramondetta L (Mentoring Author). Analysis of cervical cancer treatment in an indigent population: How are we using hospital resources?. Update in Obstetrics and Gynecology 2004, The St. Regis Hotel, Houston, TX, 6/2004.
40. Basen-Engquist K, Scruggs S, Taylor CC, Jhingran A, Bodurka DC, Lu KH, Ramondetta LM, Shinn EH. Obesity and physical functioning in endometrial cancer survivors. Proceedings of the 25th Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine, Marriott Waterfront Hotel, Baltimore, MD, 3/2004.
41. Jenkins AD, Ramondetta LM (Mentoring Author), Johnston T, Sun CC, Wolf JK, Bodurka DC, Atkinson EN, Levenback CF. A phase II study of capecitabine in recurrent squamous cell carcinoma of the cervix. Proceedings of the 35th Annual Meeting of the Society of Gynecologic Oncologists, San Diego Marriott Hotel & Marina, San Diego, CA, 2/2004.
42. Ramondetta LM, Slomovitz B, Caudell JJ, Lu KH, Broaddus RR, Gershenson DM, Deavers MT. Imatinib mesylate (Gleevec)-targeted kinases are expressed in uterine sarcomas. Proceedings of the 35th Annual Meeting of the Society of Gynecologic Oncologists, San Diego Marriott Hotel & Marina, San Diego, CA, 2/2004.
43. Brown J, Shvartsman H, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. Taxane-based chemotherapy compared with bleomycin, etoposide, and cisplatin for the treatment of sex cord-stromal ovarian tumors. Proceedings of the 35th Annual Meeting of the Society of Gynecologic Oncologists, San Diego Marriott Hotel & Marina, San Diego, CA, February 7-11, 2004. Gynecol Oncol 92:402, 2004.
44. Orejuela FJ, Ramondetta LM (Mentoring Author), Hollier L, Li Y, Lemos L, Broaddus R. Estrogen and progesterone receptors and cyclooxygenase-2 expression in normal endometrium, endometrial hyperplasia and endometrial adenocarcinoma. Updates in Obstetrics and Gynecology, 2003, Presented by the University of Texas Medical School at Houston, Department of Obstetrics, Gynecology & Reproductive Sciences and Memorial Hermann Hospital, The St. Regis Hotel, Houston, TX, 6/2003.
45. Ramondetta LM, Robinson JB, Li Y, Burke TW, Broaddus R. Effect of mifepristone on endometrial cancer cell lines. Proceedings of the 39th Annual Meeting of the American Society of Clinical Oncology, McCormick Place Hotel, Chicago, IL, 5/2003.
46. Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Gleevec (imatinib mesylate) targeted kinases are activated in uterine sarcomas. Proceedings of the 44th Annual Clinical Conference: Molecular Therapeutics for Cancer Metastasis. The University of Texas M. D. Anderson Cancer Center, J. W. Marriott Hotel, 3/2003.
47. Pothuri B, Ramondetta LM, Deavers MT, Barakat RR Soslow R. p53 immunoreactivity in endometrial cancers developing after radiation treatment for cervical cancer. Proceedings of the United States of Canadian Academy of Pathology 92nd Annual Meeting, Marriott Wardman Park, Washington, DC, 3/2003.
48. Slomovitz BM, Ramondetta LM, Oh J, Lee C, Jhingran A, Eifel PJ, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant treatment. Proceedings of the Annual Meeting of the American Radium Society, 2003.
49. Ramondetta LM, Broaddus R, Wolf J, Levenback C, Bevers M, Burke TW. A phase II trial of cisplatin and ifosfamide/mesna in patients with advanced or recurrent uterine mixed mullerian tumors. Proceedings of the American Society of Clinical Oncology Annual Meeting, Session title: Gynecologic Cancer: Advances in therapy, 5/2002.
50. Pothuri B, Ramondetta LM (Mentoring Author), Martino M, Alektiar K, Eifel PJ, Deavers MT, Venkatraman E, Soslow RA, Barakat RR. Development of endometrial cancer after radiation treatment for cervical carcinoma. Proceedings of the American Society of Clinical Oncology Annual Meeting, Orlando, FL, 5/2002.
51. Schimp VL, Ramondetta LM, Jenkins AW, Modesitt SC, Zu Z, Burke TW, Wolf JK. In vivo adenovirus-mediated p53, p21, and p16 tumor suppressor therapy in uterine papillary serous adenocarcinoma. Proceedings of the American Association of Cancer Research Annual Meeting 43:83, 4/2002.
52. Broaddus RR Ramondetta LM. Estrogen receptor (ER), progesterone receptor (PR), KIT (CD117), and HER-2/neu immunohistochemical expression in uterine malignant mixed mullerian tumors. Mod Pathol 15:192A, 2002.
53. Holtz D, Ramondetta LM (Mentoring Author), Burke TW, Palazzo JP, Dunton CJ, Atkinson EN, Broaddus R. PTEN expression in tamoxifen-associated endometrial cancers. Proceedings of the American Association of Cancer Research Annual Meeting, Poster Session Cell and Tumor Biology (10)43:455 (#2258), 2002.
54. Oh Jonathan, Ramondetta LM (Mentoring Author), Fritsche HA, Bast RC, Mills GB, Wolf JK. Serum IGF-1, IGFBP-2, and IGFBP-3 in advanced ovarian cancer. Proceedings of the American Association for Cancer Research Annual meeting, Poster Session Cell and Tumor Biology 10 43:189 (#106174), 2002.
55. Callister M, Jhingran A, Ramondetta LM, Burke TW, Eifel P. Malignant mixed mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcomes. Proceedings of the American Radium Society 83rd Annual Meeting, 2001.
56. Wolf JK, Fightmaster D, Ramondetta L, Ramirez P, Mills G, Gershenson DM. Chemotherapy plus adenovirus-p53 gene therapy: The effect of combination therapy on cell growth, arrest, and apoptosis. Gynecol Oncol 72:457, 1999.
57. Ramirez P, Gershenson DM, Ramondetta L, Fightmaster D, Wharton JT, Wolf JK. Expression of the cell cycle mediators Bax, bcl-2, mdm-2, and Rb in ovarian cancer cells after transduction with p16, p21 and p53. Cancer Res 40:221 (#1469), 1999.

Book Chapters

1. Ramondetta LM, Fields MM, Fisch MJ. Cervix Cancer Supportive Care. In: Cervical Cancer: State of the Art. Remecia Medical Education and Publishing: London, UK. In Press.
2. Ramondetta LM, Fields MM, Fisch MJ. Supportive Care: Chapter 14. In: Ovarian Cancer: State of the Art. Remecia Medical Education and Publishing: London, UK, 185-227, 2009.
3. Euscher E, Lacour R, Ramondetta L. Predictors of Outcome in Malignant Mixed Mullerian Tumors of the Uterus (Chapter 15). In: In Prognostic and Predictive Factors in Gynecologic Cancers. Ed(s) Levenback CF, Sood AK, Lu KH, Coleman RL. Informa HealthcareUK Ltd, London: London, England, 2007.
4. Ramondetta LM, Sills D. Spirituality and Religion in the "Art of Dying". In: Annual Editions: Dying, Death, and Bereavement, Unit 3. The Dying Process. (16). Contemporary Learning Series: Dubuque, IA, 89-91, 2007.
5. Ramondetta LM, Jenkins D. Spiritual Suffering of the Cancer Pain Patient. In: Practical Aspects of Cancer Pain Management. Ed(s) Fisch M, Burton A. McGraw-Hill Publishers: Columbus, OH, 2006.
6. Ramondetta LM, Bodurka DC, Deavers M, Jhingran A. The treatment of uterine sarcomas. In: Eifel PJ, Gershenson DM, Kavanagh JJ, Silva EG (eds.) M. D. Anderson Cancer Care Series, Gynecologic Cancer. 9, 125-147, 2006.
7. Ramondetta LM, Burke TW, Broaddus R, Jhingran A. Treatment of endometrial cancer. In: Eifel PJ, Gershenson DM, Kavanagh JJ, Silva EG (eds.) M. D. Anderson Cancer Care Series, Gynecologic Cancer. 10, 148-174, 2006.
8. Ramondetta LM Lu KH. Controversies in endometrial cancer screening, diagnosis, and staging. Chapter 17. In: Gynecologic Cancer: Controversies in Management. Churchill Livingstone, The Curtis Center, 241-247, 2004.

Books (edited and written)

1. Lois M. Ramondetta, MD and Deborah Rose Sills, Ph.D. The Light Within; If not now, when? William Morrow, Harper Collins, 2008.

Manuals, Teaching Aids, Other Teaching Publications

1. Ramondetta, LM. Patient Education Information (Update). Cervical Cancer Module for US News & World Report website, 2009.
2. Ramondetta LM. Patient Education Information. Cervical Cancer Module for US News & World Report website, 2007.
3. Ramondetta, LM. Resident and student responsibilities of the gynecologic oncology and colposcopy service handbook, 2001.
 

Other

1. Video Commentary on Cervix Cancer Questions.

Real Health TV Project, 2007

.
2. University of Texas Pod Cast.

The University of Texas M.D. Anderson Cancer Center, Physician Communicate, September 2008

.
3. University of Texas Pod Cast.

The University of Texas M.D. Anderson Cancer Center, The Light Within Excerpts, November 12, 2008

.
4. Webcast. Patient Power.

Advances in the Treatment of Uterine Cancer, Sponsored by America's Top Medical Centers, January 20, 2009

.
5. Newsweek: The Doctor Factor.

Book Review; The Light Within; Doctors and patients who battle cancer together can develop a unique bond: corned beef on chemo day. June 14, 2008

 

.
6. The Wall Street Journal.

The Informed Patient; Review-The Light Within, December 24, 2008 

.
7. University of Texas Webinar.

The University of Texas M.D. Anderson Cancer Center, The Women's Fund.  Be prepared for your next doctor's visit - 2012 Cervical Screening Guidelines. January 9, 2012

.
8. Houston Chronicle, Health Zone.

A vaccine's promise, HPV inoculations gaining acceptance. Cover story, Section K, February 24, 2013.

.
9. M.D. Anderson Cancer Center Annual Report.

The Time Is Now, First Cervical Cancer Summit review article, A patchwork of partners, Annual Report 2011-2012, page 43.

.
10. M.D. Anderson Cancer Center Video Commentary. Pelvic Exenteration Module, UT Television video commentary, June 13, 2013.
11. Coping Webside and e-Update. The Importance of Hope, Wellness and Emotional Support.  Feature article March 18-31, 2012.

Last updated: 6/24/2014